SELLAS Life Sciences Group, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
SELLAS Life Sciences Group, Inc. (SLS) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $3.70 million as of 2017-12-31, per its 10-K filed 2018-04-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2018-04-13
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.70M.
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $200.00M.
- 2015-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $183.50M.
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $145.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2017-12-31 | $3.70M 10-K · filed 2018-04-13 |
| 2016-12-31 | $200.00M 10-K · filed 2017-03-15 |
| 2015-12-31 | $183.50M 10-K/A · filed 2016-04-15 |
| 2014-12-31 | $145.90M 8-K · filed 2015-12-04 |
| 2013-12-31 | $49.80M 10-K · filed 2014-03-17 |
| 2012-12-31 | $50.50M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |